As NGS panels increase in size and complexity, many clinical labs are asking, “How do we scale up without requiring more staff?”

QIAGEN Clinical Insight (QCI) Interpret One is clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting of oncology NGS tests at scale.

Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.


In this webinar, attendees will learn:

• How QCI Interpret One computes variant classifications
• 
  How simple it is to submit variants for professional interpretation via the software
• 
  How QCI Interpret One eliminates the need for variant curation
• 
  How users can generate customizable, oncologist-ready reports according to EMA/ESMO/ELN/WHO guidelines for therapeutic, prognostic, and diagnostic actionability

Interested in learning more?

Click here

Speakers:
Beate Litzenburger, PhD, Global Product Director of Oncology for Clinical Decision Support Software and Interpretation Services at QIAGEN
Sheryl Krevsky Elkin, PhD, Chief Scientific Officer at N-of-One, a QIAGEN company